litlas
ログインアカウント作成

Péter Ferenci

1983–2025 年に発表

別表記
Peter Ferenci
138
論文数
31,993
被引用数
93
h 指数
137
i10 指数

被引用数

Péter Ferenci の年別被引用数1984 年: 被引用 1 件1985 年: 被引用 1 件1986 年: 被引用 1 件1987 年: 被引用 3 件1988 年: 被引用 5 件1989 年: 被引用 6 件1990 年: 被引用 11 件1991 年: 被引用 13 件1992 年: 被引用 15 件1993 年: 被引用 11 件1994 年: 被引用 11 件1995 年: 被引用 12 件1996 年: 被引用 12 件1997 年: 被引用 33 件1998 年: 被引用 32 件1999 年: 被引用 35 件2000 年: 被引用 62 件2001 年: 被引用 46 件2002 年: 被引用 80 件2003 年: 被引用 98 件2004 年: 被引用 90 件2005 年: 被引用 108 件2006 年: 被引用 116 件2007 年: 被引用 190 件2008 年: 被引用 150 件2009 年: 被引用 129 件2010 年: 被引用 177 件2011 年: 被引用 195 件2012 年: 被引用 251 件2013 年: 被引用 250 件2014 年: 被引用 293 件2015 年: 被引用 260 件2016 年: 被引用 209 件2017 年: 被引用 217 件2018 年: 被引用 173 件2019 年: 被引用 687 件2020 年: 被引用 586 件2021 年: 被引用 589 件2022 年: 被引用 533 件2023 年: 被引用 397 件2024 年: 被引用 533 件2025 年: 被引用 248 件2026 年: 被引用 9 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,688 件、この内訳の 20.5%ドイツ: 引用元論文 584 件、この内訳の 7.1%中国: 引用元論文 571 件、この内訳の 6.9%イタリア: 引用元論文 533 件、この内訳の 6.5%イギリス: 引用元論文 481 件、この内訳の 5.8%フランス: 引用元論文 390 件、この内訳の 4.7%スペイン: 引用元論文 387 件、この内訳の 4.7%カナダ: 引用元論文 337 件、この内訳の 4.1%オーストリア: 引用元論文 253 件、この内訳の 3.1%日本: 引用元論文 224 件、この内訳の 2.7%インド: 引用元論文 218 件、この内訳の 2.7%オーストラリア: 引用元論文 186 件、この内訳の 2.3%
0%20.5%その他 28.9%

機関

分野

  • Medicine76.8%
  • Nursing12.6%
  • Biochemistry, Genetics and Molecular Biology4.9%
  • Pharmacology, Toxicology and Pharmaceutics1.5%
  • Neuroscience1.1%
  • Agricultural and Biological Sciences0.5%
  • その他2.6%

トピック

  • Liver Disease Diagnosis and Treatment13.1%
  • Hepatitis C virus research10.2%
  • Liver Disease and Transplantation10.1%
  • Hepatitis B Virus Studies5.6%
  • Trace Elements in Health4.4%
  • Organ Transplantation Techniques and Outcomes3.4%
  • その他53.2%

共著者

全論文

検索で開く
  1. Wilson disease

    著者: Anna Członkowska, Tomasz Litwin, Petr Dušek, Péter Ferenci, Svetlana Lutsenko, Valentina Medici, Janusz Rybakowski, Karl Heinz Weiss, Michael L. Schilsky - Nature Reviews Disease Primers 2018 被引用: 886

  2. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver

    著者: Hendrik Vilstrup, Piero Amodio, Jasmohan S. Bajaj, Juan Córdoba, Péter Ferenci, Kevin D. Mullen, Karin Weißenborn, Philip Wong - Hepatology 2014 被引用: 2,047

  3. Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease

    著者: Katharina Staufer, Ursula Huber-Schönauer, Georg Strebinger, Philipp Pimingstorfer, Silke Suesse, Thomas–Matthias Scherzer, Bernhard Paulweber, Péter Ferenci, Thomas Stimpfl, Michel Yegles, Christian Datz, Michael Trauner - Journal of Hepatology 2022 被引用: 179

  4. Diagnosis and phenotypic classification of Wilson disease1

    著者: Péter Ferenci, Karel Caca, Georgios Loudianos, Giorgina Mieli‐Vergani, Stuart Tanner, Irmin Sternlieb, Michael L. Schilsky, Diane W. Cox, Frieder Berr - Liver International 2003 被引用: 921

  5. HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease

    著者: Georg Semmler, Elias Laurin Meyer, K Kozbial, Philipp Schwabl, Stefanie Hametner‐Schreil, Alberto Zanetto, David Bauer, David Chromy, Benedikt Simbrunner, Bernhard Scheiner, Albert Friedrich Stättermayer, Matthias Pinter, R Schöfl, Francesco Paolo Russo, Helena Greenfield, Michael Schwarz, Caroline Schwarz, Michael Gschwantler, Sonia Alonso López, María Luisa Manzano, Adriana Ahumada, Rafael Bañares, Mònica Pons, Sergio Rodríguez‐Tajes, Joan Genescà, Sabela Lens, Michael Trauner, Péter Ferenci, Thomas Reiberger, Mattias Mandorfer - Journal of Hepatology 2021 被引用: 133

  6. Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study

    著者: Karl Heinz Weiss, Frederick K. Askari, Anna Członkowska, Péter Ferenci, Jeff M. Bronstein, Danny Bega, Aftab Ala, David Nicholl, Susan Flint, Lars Olsson, Thomas Plitz, Carl Bjartmar, Michael L. Schilsky - ˜The œLancet. Gastroenterology & hepatology 2017 被引用: 169

  7. Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998

    著者: Péter Ferenci, Alan H. Lockwood, Kevin D. Mullen, Ralph E. Tarter, Karin Weißenborn, Andrés T. Blei - Hepatology 2002 被引用: 2,033

  8. Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

    著者: Mattias Mandorfer, K Kozbial, Philipp Schwabl, C Freissmuth, Rémy Schwarzer, R Stern, David Chromy, Albert Friedrich Stättermayer, Thomas Reiberger, S. Beinhardt, Wolfgang Sieghart, Michael Trauner, Harald Hofer, Arnulf Ferlitsch, Péter Ferenci, Markus Peck‐Radosavljevic - Journal of Hepatology 2016 被引用: 301

  9. Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon‐Free Therapy

    著者: Mattias Mandorfer, K Kozbial, Philipp Schwabl, David Chromy, Georg Semmler, Albert Friedrich Stättermayer, Matthias Pinter, Virginia Hernández–Gea, Monika Fritzer‐Szekeres, Petra Steindl‐Munda, Michael Trauner, Markus Peck‐Radosavljevic, Juan Carlos García‐Pagán, Péter Ferenci, Thomas Reiberger - Hepatology 2019 被引用: 160

  10. Clinical presentation, diagnosis and long-term outcome of Wilson’s disease: a cohort study

    著者: Uta Merle, Mark Schaefer, Péter Ferenci, Wolfgang Stremmel - Gut 2006 被引用: 624

  11. World Gastroenterology Organisation Global Guidelines

    著者: Douglas R. LaBrecque, Zaigham Abbas, Frank A. Anania, Péter Ferenci, Aamir Khan, Khean‐Lee Goh, Saeed Hamid, Isakov Va, Maribel Lizarzábal, Manuel M. Peñaranda, Juan Francisco Rivera Ramos, Shiv Kumar Sarin, Davor Štimac, A. B. R. Thomson, Muhammed Umar, Justus Krabshuis, Anton LeMair - Journal of Clinical Gastroenterology 2014 被引用: 521

  12. Long-term Outcomes of Patients With Wilson Disease in a Large Austrian Cohort

    著者: S. Beinhardt, Waltraud Leiss, Albert Friedrich Stättermayer, Ivo Graziadei, Heinz Zoller, Rudolf Stauber, A Maieron, Christian Datz, Petra Steindl‐Munda, Harald Hofer, Wolfgang Vogel, Michael Trauner, Péter Ferenci - Clinical Gastroenterology and Hepatology 2013 被引用: 188

  13. Age and Sex but Not ATP7B Genotype Effectively Influence the Clinical Phenotype of Wilson Disease

    著者: Péter Ferenci, Wolfgang Stremmel, Anna Członkowska, Ferenç Szalay, André Viveiros, Albert Friedrich Stättermayer, Radan Brůha, Roderick H.J. Houwen, Tudor Lucian Pop, Rudolf Stauber, Michael Gschwantler, Jan Pfeiffenberger, Cihan Yurdaydın, Elmar Aigner, Petra Steindl‐Munda, Hans‐Peter Dienes, Heinz Zoller, Karl Heinz Weiss - Hepatology 2018 被引用: 185

  14. MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective

    著者: Yasser Fouad, Jeffrey V. Lazarus, Francesco Negro, Markus Peck‐Radosavljevic, Shiv Kumar Sarin, Péter Ferenci, Gamal Esmat, Hasmik Ghazinian, Atsushi Nakajima, Marcelo Silva, Samuel Lee, Massimo Colombo - Alimentary Pharmacology & Therapeutics 2021 被引用: 45

  15. Efficacy and Safety of Oral Chelators in Treatment of Patients With Wilson Disease

    著者: Karl Heinz Weiss, Florentine F. Thurik, Daniel Gotthardt, Mark A. Schafer, Ulrike Teufel, Franziska Wiegand, Uta Merle, Daniela Ferenci–Foerster, A Maieron, Rudolf Stauber, Heinz Zoller, Hartmut Schmidt, Ulrike Reuner, Harald Hefter, Jean Marc Trocello, Roderick H.J. Houwen, Péter Ferenci, Wolfgang Stremmel - Clinical Gastroenterology and Hepatology 2013 被引用: 249

  16. Response‐guided long‐term treatment of chronic hepatitis D patients with bulevirtide—results of a “real world” study

    著者: Mathias Jachs, Caroline Schwarz, Marlene Panzer, Teresa Binter, Stephan W. Aberle, Lukas Hartl, K Dax, Elmar Aigner, Albert Friedrich Stättermayer, Petra Munda, Ivo Graziadei, Heidemarie Holzmann, Michael Trauner, Heinz Zoller, Michael Gschwantler, Mattias Mandorfer, Thomas Reiberger, Péter Ferenci - Alimentary Pharmacology & Therapeutics 2022 被引用: 74

  17. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults

    著者: Albert Friedrich Stättermayer, Emina Halilbasic, Fritz Wrba, Péter Ferenci, Michael Trauner - Journal of Hepatology 2020 被引用: 109

  18. Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease

    著者: Rafael Paternostro, Katharina Staufer, Stefan Traussnigg, Albert Friedrich Stättermayer, Emina Halilbasic, Omar Keritam, Elias Laurin Meyer, Judith Stift, Fritz Wrba, Bence Sipos, Ali Canbay, Martin Schlattjan, Elmar Aigner, Christian Datz, Felix Stickel, Clemens Schafmayer, Jochen Hampe, Stephan Buch, Gerhard Prager, Petra Munda, Mattias Mandorfer, Péter Ferenci, Michael Trauner - Hepatology International 2021 被引用: 36

  19. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing

    著者: Péter Ferenci - Human Genetics 2006 被引用: 266

  20. Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression

    著者: Mathias Jachs, Marlene Panzer, Lukas Hartl, Michael Schwarz, Lorenz Balcar, Jeremy V. Camp, Petra Munda, Mattias Mandorfer, Michael Trauner, Stephan W. Aberle, Heinz Zoller, Thomas Reiberger, Péter Ferenci - JHEP Reports 2023 被引用: 27

  21. ESPEN Guidelines on Enteral Nutrition: Liver disease

    著者: Mathias Plauth, Eduard Cabré, Oliviero Riggio, M. Assis-Camilo, Matthias Pirlich, Jens Kondrup, Péter Ferenci, E. Holm, S. vom Dahl, Manfred J. Müller, W. Nolte - Clinical Nutrition 2006 被引用: 683

  22. Clinical and virological heterogeneity of hepatitis delta in different regions world‐wide: The Hepatitis Delta International Network (HDIN)

    著者: Anika Wranke, Lourdes Maria Pinheiro Borzacov, Raymundo Paraná, Cirley Lobato, Saeed Hamid, Emanoil Ceaușu, George Ν. Dalekos, Mario Rizzetto, Adela Turcanu, Grazia Anna Niro, Farheen Lubna, Minaam Abbas, Patrick Ingiliz, Marı́a Buti, Péter Ferenci, Thomas Vanwolleghem, Tonya Hayden, Naranjargal Dashdorj, Adriana Moţoc, Markus Cornberg, Zaigham Abbas, Cihan Yurdaydın, Michael P. Manns, Heiner Wedemeyer, Svenja Hardtke, the Hepatitis Delta International Network - Liver International 2017 被引用: 91

  23. Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease

    著者: Georg Semmler, Teresa Binter, K Kozbial, Philipp Schwabl, Stefanie Hametner‐Schreil, Alberto Zanetto, Sabrina Gavasso, David Chromy, David Bauer, Benedikt Simbrunner, Bernhard Scheiner, Theresa Bucsics, Albert Friedrich Stättermayer, Matthias Pinter, Petra Steindl‐Munda, R Schöfl, Francesco Paolo Russo, Paolo Simioni, Michael Trauner, Péter Ferenci, Thomas Reiberger, Mattias Mandorfer - Hepatology 2020 被引用: 74

  24. Partial pressure of ammonia versus ammonia in hepatic encephalopathy

    著者: Ludwig Kramer, Barbara Tribl, Alexandra Gendo, Christian Zauner, Barbara Schneider, Péter Ferenci, Christian Madl - Hepatology 2000 被引用: 168